HBZ and neoplasm: The lack of suitable reagents such as monoclonal antibodies against the native, endogenous HBZ has not permitted to corroborate and validate all the functions attributed to HBZ, particularly in naturally HTLV-1 infected cells and in tumor cells of ATL patients.